company background image
990 logo

Chengzhi XSEC:000990 Stock Report

Last Price

CN¥7.55

Market Cap

CN¥9.2b

7D

2.9%

1Y

-13.1%

Updated

17 Apr, 2024

Data

Company Financials +

990 Stock Overview

Chengzhi Co., Ltd. engages in the clean energy, functional materials, medical healthcare, and life science and technology related businesses in China.

990 fundamental analysis
Snowflake Score
Valuation4/6
Future Growth2/6
Past Performance1/6
Financial Health6/6
Dividends0/6

Chengzhi Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Chengzhi
Historical stock prices
Current Share PriceCN¥7.55
52 Week HighCN¥8.76
52 Week LowCN¥5.96
Beta0.58
1 Month Change2.17%
3 Month Change-2.71%
1 Year Change-13.12%
3 Year Change-42.59%
5 Year Change-69.72%
Change since IPO-54.10%

Recent News & Updates

Recent updates

Shareholder Returns

990CN ChemicalsCN Market
7D2.9%-2.8%-0.2%
1Y-13.1%-25.0%-17.8%

Return vs Industry: 000990 exceeded the CN Chemicals industry which returned -28.5% over the past year.

Return vs Market: 000990 exceeded the CN Market which returned -21.1% over the past year.

Price Volatility

Is 990's price volatile compared to industry and market?
990 volatility
990 Average Weekly Movement6.9%
Chemicals Industry Average Movement8.9%
Market Average Movement8.9%
10% most volatile stocks in CN Market12.7%
10% least volatile stocks in CN Market5.4%

Stable Share Price: 000990 has not had significant price volatility in the past 3 months.

Volatility Over Time: 000990's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19984,195Junmin Weiwww.chengzhi.com.cn

Chengzhi Co., Ltd. engages in the clean energy, functional materials, medical healthcare, and life science and technology related businesses in China. The company produces and sells gas products, including carbon monoxide and purified synthesis gas, and industrial chemical products, such as ethylene, propylene, butanol, octanol, isobutyraldehyde, amino acid series products, and other pharmaceutical intermediates, as well as non-display materials, such as TFT- LCD liquid crystal materials, TV, MNT, NB, MB, TPC, vehicle, industrial control, PDLC, OLED materials, mixed liquid crystal materials, and glass products for display. It also produces and sells life science and technology products, such as D-ribose, arbutin, Lipox, D-ribose granule, and other biopharmaceutical and pharmaceutical intermediates, as well as cannabinoids, including CBDV and CBC.

Chengzhi Co., Ltd. Fundamentals Summary

How do Chengzhi's earnings and revenue compare to its market cap?
990 fundamental statistics
Market capCN¥9.18b
Earnings (TTM)CN¥388.43m
Revenue (TTM)CN¥11.77b

23.6x

P/E Ratio

0.8x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
990 income statement (TTM)
RevenueCN¥11.77b
Cost of RevenueCN¥9.93b
Gross ProfitCN¥1.85b
Other ExpensesCN¥1.46b
EarningsCN¥388.43m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.32
Gross Margin15.68%
Net Profit Margin3.30%
Debt/Equity Ratio20.1%

How did 990 perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.